Biome Australia Limited (ASX:BIO) Reports First Net Profit and Unveils Vision 27 Strategic Plan
Financial Performance
Biome Australia reported its first net profit of $96,228 (excluding R&D rebate) and $433,395 (including R&D rebate) for H1 FY25. The company achieved positive EBITDA of $351,765 and recorded a 61% gross margin. Sales revenue reached a record $8.86m for H1 FY25 and $4.6m in Q2 FY25, marking an 89% increase from Q1.
Business Highlights
Biome Australia expanded its Australian distribution footprint by 20%, reaching 6000 distribution points. The company successfully completed in-vitro research on strain BMB18 and entered a partnership with FaBA for matched research funding. Additionally, Biome launched its cholesterol-lowering probiotic, Biome Cholesterol™ Probiotic, and successfully entered the Canadian market with Ecotrend Ecologics.
Vision 27 Strategic Plan
Biome introduced Vision 27, a three-year plan targeting $75-$85m in cumulative revenue from FY25-27. The plan focuses on distribution growth, international market expansion, supply chain development, and launching a new brand and product range.
Executive Comments
Managing Director and Founder Blair Vega Norfolk stated, “The first half of the financial year 2025 has been a remarkable six months for Biome. The milestones, momentum, and scale throughout this period have set the business up well for ongoing success. On a number of metrics Biome is ahead of schedule in the execution of the Vision 27 strategic plan. After another two quarters of positive EBITDA, the business has announced its maiden net profit, a major achievement. I look forward to what is ahead for Biome and sharing further updates on our exciting journey to become one of the highest impact and scalable business in the global probiotic and complementary medicine space.”
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.